Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0757d41b989146e4adc7a8112459ed8c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1656ceba5d333f35fab36d565e79e3b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7de28ee6cc3aafbf9aadef056cf377c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10beb6efc02057c348f8abbe49c648e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24f575d0dbd434439b88d7edb6889f17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b42b6463e0632b53b52cde8e2d4437e |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2011-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35241686ae4e6fee639bbf290b8c9503 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98b4e457b5277ff2d408be7868d46838 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7de03fa6b41cda745a70a447ece351d9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d27ed7f54d19f4a9e1eacc40990bbd6a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87751571b36aa1fb3e30c748fe08e484 |
publicationDate |
2012-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2012010661-A1 |
titleOfInvention |
Methods for determining a prognosis for survival for a patient with leukaemia |
abstract |
A method for determining a prognosis for survival for a patient with leukaemia is described. Also described is a method for monitoring the effectiveness of a course of treatment for a patient with leukaemia, and the use of such a method in a kit. A kit determining the level of RINF is also described. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019215394-A1 |
priorityDate |
2010-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |